Defined source and culture conditions
Human umbilical-cord-derived stem-cell conditioned medium. Culture is xeno-free; collection uses medium without added protein or insulin.
6 cc · 12 cc · 18cc | 1, 5 or 10 visits
Book a consultation ↗Treatment models welcome year-round. Model pricing is determined at consultation.

| Choose visits | Total contract price | Per visit | Per-visit difference | Per-visit reduction from baseline |
|---|
The selected registered plan is the comparison baseline; this is not necessarily a discount from a regular single visit. Difference = baseline per-visit rate × chosen visits − chosen total. Values are rounded only for display. First-visit and ticket conditions remain separate. Different areas and quantities are not combined. A doctor determines suitable visit counts.
An IV service using human umbilical-cord-derived stem-cell conditioned medium, not live cells. Review the EV-containing preparation, quality records, unapproved status, costs and risks. Benefits for beauty or health and safety are not established.
Review pregnancy, breastfeeding, cancer history, infection, allergies and medicines. A doctor assesses suitability, quantity and visits.
Allow about 60–90 minutes including the first consultation. Composition, testing records, costs and unapproved status are explained before consent and infusion.
The infusion site and general condition are checked. The clinic advises avoiding blood donation afterward. Discuss follow-up intervals with the doctor.
Risks include pain, bruising, vein irritation, feeling unwell, fever, allergy and infection. Serious adverse events from unapproved exosome products have been reported overseas. Japan’s adverse drug reaction relief scheme does not cover this service.
This guide combines general information with the clinic’s published menus. Overseas approvals and indications differ from Japan; confirm suitability for the exact product, device and delivery method at consultation.
Our doctor selects the preparation by reviewing its source, culture process and batch testing. These are the quality controls described in our dedicated guide.
Human umbilical-cord-derived stem-cell conditioned medium. Culture is xeno-free; collection uses medium without added protein or insulin.
Every production batch undergoes sterility, mycoplasma and endotoxin testing. Manufacturing, test and distribution records, plus retained samples, support traceability.
NTA measures particle size and count; ELISA checks CD9, CD63 and CD81. Published measurements cover 218 analytes: 66 growth factors, 91 cytokines/chemokines and 61 neural factors.
Based on the supplier process and measurements described in our clinic guide. Measurements are not guaranteed contents for every batch, proof of treatment benefit or superiority over other products. The administered material is cell-free conditioned medium, not isolated purified exosomes. This is unapproved private care; efficacy and safety are not established.
Read the full preparation & testing guide ↗An IV service using human umbilical-cord-derived stem-cell conditioned medium, not live cells. Review the EV-containing preparation, quality records, unapproved status, costs and risks. Benefits for beauty or health and safety are not established.
The infusion site and general condition are checked. The clinic advises avoiding blood donation afterward. Discuss follow-up intervals with the doctor.
Checked 2026-09-22: Exosomes IV infusion 6cc / 1 sessions has a total plan price of JPY 48,000 excluding tax (JPY 52,800 including tax). First-visit, photo-monitor and concurrent-treatment conditions apply where stated. Confirm area, quantity and any anaesthesia or other additional charges before treatment.
Course pricing is available upon consultation.
Please confirm the number of sessions, treatment area and eligibility during your consultation. Single-session prices are listed below.
Ask about a course| Plan | Sessions | Total contract price | Per session |
|---|---|---|---|
| Exosomes IV infusion 6cc / 1 sessions | 1 | ¥48,000 | ¥48,000 |
| Exosomes IV infusion 6cc / 5 sessions | 5 | ¥220,000 | ¥44,000 |
| Exosomes IV infusion 6cc / 10 sessions | 10 | ¥400,000 | ¥40,000 |
| Exosomes IV infusion 12cc / 1 sessions | 1 | ¥88,000 | ¥88,000 |
| Exosomes IV infusion 12cc / 5 sessions | 5 | ¥400,000 | ¥80,000 |
| Exosomes IV infusion 12cc / 10 sessions | 10 | ¥720,000 | ¥72,000 |
| Exosomes IV infusion 18cc / 1 sessions | 1 | ¥130,000 | ¥130,000 |
| Exosomes IV infusion 18cc / 5 sessions | 5 | ¥585,000 | ¥117,000 |
| Exosomes IV infusion 18cc / 10 sessions | 10 | ¥1,100,000 | ¥110,000 |
Private care using unapproved stem-cell conditioned medium. Efficacy and safety are not established.
エクソソーム 点滴 6cc / 1回|税抜 48,000円 エクソソーム 点滴 6cc / 5回|税抜 220,000円 エクソソーム 点滴 6cc / 10回|税抜 400,000円 エクソソーム 点滴 12cc / 1回|税抜 88,000円 エクソソーム 点滴 12cc / 5回|税抜 400,000円 エクソソーム 点滴 12cc / 10回|税抜 720,000円 エクソソーム 点滴 18cc / 1回|税抜 130,000円 エクソソーム 点滴 18cc / 5回|税抜 585,000円 エクソソーム 点滴 18cc / 10回|税抜 1,100,000円
Price information checked: 22 September 2026. Prices and eligibility may change.
Tirzepatide is a weekly injectable acting on GIP and GLP-1 receptors, with effects on glucose regulation and appetite. The clinic offers doctor-led weight-management consultation. Cosmetic weight reduction differs from GLP-1’s approved Japanese indication.
Japanese-market 2.5, 5 and 7.5 mg pens. One pricing month = 4 pens.
Consultation menus for vitamin, glutathione and other infusions or injections. Evidence, dose and route differ by product; brightening or fatigue relief is not guaranteed. Exosome infusions do not share the evidence or safety profile of routine nutrient replacement.
Check each plan for area, quantity and method.
11F, HULIC & New GINZA 8
8-9-7 Ginza, Chuo-ku, Tokyo 104-0061, Japan
About 3 min from Shimbashi · About 7 min from Ginza Station
Get directions on Google Maps ↗